The Methodist Hospital Research Institute

Houston, TX Part of The Methodist Hospital

UEI
XJUCJAYJWYV1
CAGE
4AGX4
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
6565 Fannin St d200, Houston, TX 77030, USA
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $6,103,473

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $6,103,473

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Travel Concepts Inc. Base IDIQ title: prevent cancer preclinical drug development program: preclinical efficacy and intermediate endpoint biomarkers 75N91025F00001 $1,122,335
Not on record US PEDIATRIC PROTON AND PHOTON THERAPY COHORT AWARD Agreement: $84,279 The contractor shall identify all proton treated pediatric patients and all photon… 75N91023P00542 $84,279
University Of Montana VACCINE ADJ DISCOVERY PROGRAM (VADP) HMRI (Dr. Dan Kiss sub-PI) is responsible for the design, production, characterization and QA/QC of mRNA based TB… 75N93019C00045 $356,698

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Leveraging whole genome sequencing and functional genomic characterization to improve NSCLP gene discovery R01DE033908 $177,300
Albert Einstein College Of Medicine PROVIDENT: Prepositioning Optimized Strategies for Vaccines and Immunotherapeutics against Diverse Emerging Infectious Threats U19AI181977 $93,632
University Of Pittsburgh - Of The Commonwealth System Of Higher Education To identify ZBP-1 is the innate immune sensor for Enteric virus infection using in vitro models. R21AI200033 $87,528
Case Western Reserve University Subaward between CWRU and Houston Methodist Hospital. R01HL167199 $38,270
The Leland Stanford Junior University ADHERES aims to 1) integrate and analyze readily available clinical and patient-generated data to narrow gaps in guideline adherence, prevent cardiovascular… R01HL168188 $163,280

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

The Methodist Hospital Research Institute, a nonprofit biomedical research organization and division of The Methodist Hospital in Houston, Texas, operates as a federal grant recipient and Other Transaction Agreement (OTA) prime—not a traditional contractor—conducting mechanism-driven translational research in immunology, molecular oncology, regenerative medicine, and infectious disease with an NIH OTA awarded September 2026 (SMART-CURE | 1CURE, $23.3 million ceiling through September 2031).

The institute's federal footprint is almost entirely grant-funded. The National Institutes of Health—particularly the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Heart Lung and Blood Institute—dominates the customer concentration, together with the Defense Health Agency. Recent representative grants include a $2.71 million NIAID award for self-adjuvanted mRNA vaccine development targeting tuberculosis (Allergy and Infectious Diseases Research, CFDA 93.855); a $1.4 million Defense Health Agency grant for novel therapeutics targeting DNA damage in atypical burns (Military Medical Research and Development, CFDA 12.420); and a $1.03 million National Eye Institute award for mitochondrial cell therapy applied to age-related macular degeneration (Vision Research, CFDA 93.867). Smaller exploratory work includes NSF-funded engineering grants in robotic nursing assistance and remote physical examination technologies, and NIH-funded workshops on neuroregeneration and biostatistics. The institute also holds a position on the Joint PEO Chemical and Biological Defense Other Transaction IDV (ANTAEUS, awarded October 2023, $10.5 million ceiling) for monoclonal antibody discovery and engineering.

Activity data shows 482 total awards (prime and sub combined) across 47 customer agencies, with 350 prime positions (73%) and 132 sub-awards (27%). The portfolio has grown from 37 awards in 2022 to 63 in 2024, with 62 awards projected to complete in the next twenty-four months. The institute operates across the Texas Medical Center in Houston (primary address 6565 Fannin Street) with affiliated Methodist hospitals including Willowbrook, Sugarland, San Jacinto, and West Houston. Service Contract Inventory data shows sparse federal services-contract activity—6 SCI records as a subcontractor across FY2022–FY2025, with 66.3 FTEs recorded in FY2024 under sub-awards and 2.7 FTEs in FY2025—reflecting that the institute's federal engagement is research-grant and OTA focused, not labor-intensive service contracting. The institute sub-awards extensively to universities including Stanford, University of Pennsylvania, Mayo Clinic, UT Health San Antonio, and UT Austin, and subcontracts on defense research through primes including University of Montana (TB vaccine research, VADP) and Travel Concepts Inc. (preclinical cancer prevention drug development). The research infrastructure includes biorepository services, flow and mass cytometry cores, transcriptomics and proteomics platforms, and nonhuman primate and transgenic mouse models, positioning the institute as a translational hub for NIH-funded mechanism-driven discovery with secondary capacity in defense innovation.

Quick answers

Is The Methodist Hospital Research Institute registered in SAM.gov?

Yes. The Methodist Hospital Research Institute's SAM.gov registration is active through December 5, 2026.

How much has The Methodist Hospital Research Institute received in federal contracts?

Federal contracts obligated $6,103,473 to The Methodist Hospital Research Institute in fiscal years 2023 through 2027.

What is The Methodist Hospital Research Institute's most recent federal award?

The Methodist Hospital Research Institute's most recent federal grant award is Mechanisms regulating tendon fibrosis and adhesion formation (F32AR085954), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on November 29, 2026.

On GovTribe

See The Methodist Hospital Research Institute's full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors